Pharmaceuticals
Business
FTC Sues to Block Amgen’s $27.8 Billion Acquisition of Horizon Therapeutics
The Federal Trade Commission (FTC) filed a lawsuit on Tuesday to block Amgen's $27.8 billion acquisition of Horizon Therapeutics. The FTC alleges that the deal would harm competition in the market for autoimmune drugs.
Amgen is a leading pharmaceutical company...
- Advertisement -
Latest News
Working remotely is the future of work
In today's evolving workplace landscape, the concept of working remotely has gained significant traction and is widely believed to...
- Advertisement -
